Compound Detail
CHEMBL34246
IPROZILAMINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL34246 |
| Name | IPROZILAMINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | UMMYPDFDLDVDCZ-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
2
Known Names
Molecular Properties
315.9
MW (Da)
2.42
ALogP
6
HBA
1
HBD
44.3
PSA (Ų)
0.68
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Activity Summary
Ki 1 meas. best 5.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dopamine receptor CHEMBL2093868 | Ki | 5.1 | 5.1 | 8000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Dopamine receptor | Ki | = | 8000.0 | nM | 5.1 | In vitro ability to displace [3H]spiroperidol from rat dopamine receptor | 7154006 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 7154006 | 10.1021/jm00354a014 | Dopamine receptor | 1 |
Data from ChEMBL 36 via Core Engine